Sept. 13, 2023

As Congress returns from August recess, one of the most critical actions they must take is to approve government funding for fiscal year (FY) 2024. Congress needs to fund the government by Sept. 30 to avoid a government shutdown. The American College of Radiology® (ACR®) is asking members to take action now by urging your congressional representatives to fund the National Institutes of Health (NIH) base budget for FY 2024, at the highest possible level, and express how a loss of funding would impact radiology research.

It is essential Congress demonstrates its commitment to biomedical research and discovery by providing the highest possible funding levels for federal research agencies and programs. Medical progress, which is dependent on this funding, could be severely hampered, and the development of groundbreaking diagnostics and therapies will be delayed, impacting patient outcomes. NIH funding encompasses support for radiology and imaging research, which includes a wide range of diagnostics, treatments, and therapeutics that benefit patients and their families.

For more information, contact Katie Grady, ACR Government Affairs Director.


Related ACR News

  • Make America Healthy Again

    President Trump released an Executive Order (EO) establishing the "Make America Healthy Again (MAHA) Commission,” Feb. 13 to be led by the new Department of Health and Human Services Secretary Robert F. Kennedy Jr.

    Read more
  • Scope of Practice Bills Introduced At State Legislative Level

    The American College of Radiology® (ACR®) is tracking more than 58 scope of practice bills across 22 states with more expected to be considered.

    Read more
  • ACR Others Challenge MAC Position on Minimally Invasive Arthrodesis of the Sacroiliac Joint

    The American College of Radiology® (ACR®) and other medical specialty societies that use or perform interventional pain and spine procedures told three of the seven Medicare Administrative Contractors (MACs) that implementation of a new policy as written could limit access to a safe, effective and durable treatment option, potentially exacerbating healthcare disparities among Medicare patients.

    Read more